The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
The Well News on MSN
FDA lists nationwide recall of over 11,000 bottles of blood pressure drug
WASHINGTON - More than 11,000 bottles of a prescription medication used to treat high blood pressure have been recalled ...
The FDA has announced a nationwide recall of more than 11,000 bottles of chlorthalidone, a medication commonly prescribed to ...
More than 11,000 bottles of a popular blood pressure medication are being recalled after lab testing showed that the drug may ...
Inventia Healthcare Limited, based in Mumbai, India, issued a voluntary recall on June 5, 2026 for certain batches of the ...
Issues with proper dissolution standards triggered Teva to issue a voluntary recall for two lots of its hypertension drug tablets Matzim LA. (Teva) () Teva issued a voluntary recall for two lots of ...
System addresses the pharmaceutical industry’s need for compliant, semi-automated testing of nanoparticle drug formulations. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) ...
When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results